Filing Details
- Accession Number:
- 0001237899-10-000047
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-20 16:59:57
- Reporting Period:
- 2010-12-17
- Filing Date:
- 2010-12-20
- Accepted Time:
- 2010-12-20 16:59:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1174475 | S Michael Brown | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-12-17 | 5,000 | $18.80 | 34,662 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-12-17 | 2,897 | $32.44 | 31,765 | No | 4 | F | Direct | |
Common Stock | Disposition | 2010-12-20 | 100 | $32.89 | 31,665 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-12-20 | 2,003 | $33.24 | 29,662 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-12-17 | 5,000 | $0.00 | 5,000 | $18.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,000 | 2013-01-02 | No | 4 | M | Direct |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- The reporting person sold 2,003 shares of Company stock on December 20, 2010 at prices ranging from $33.00 to $33.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2010 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.